Bryn Mawr Trust CO Biotechnology

Bryn Mawr Trust CO

$5.48 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NVO Novo Nordisk A S	$183B	$3.45 Million 0.06% of portfolio	28,999	Q3 2024 Added 86.34%
VRTX Vertex Pharmaceuticals Inc	$110B	$2.19 Million 0.04% of portfolio	4,702	Q3 2024 New
REGN Regeneron Pharmaceuticals, Inc.	$73.7B	$1.9 Million 0.03% of portfolio	1,810	Q3 2024 Added 193.35%
RVMD Revolution Medicines, Inc.	$3.53B	$800,000 0.01% of portfolio	17,667	Q3 2024 New
ABSI Absci Corp	$269M	$723,000 0.01% of portfolio	189,522	Q3 2024 New
ARGX Argenx Se	$35.8B	$651,000 0.01% of portfolio	1,202	Q3 2024 New
TECH Bio Techne Corp	$3.09B	$371,000 0.01% of portfolio	4,651	Q3 2024 Added 55.29%
ADCT Adc Therapeutics Sa	$142M	$315,000 0.01% of portfolio	100,000	Q3 2024 New
LGND Ligand Pharmaceuticals Inc	$1.89B	$180,000 0.0% of portfolio	1,800	Q3 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$2.8B	$82,000 0.0% of portfolio	1,489	Q3 2024 New
ANVS Annovis Bio, Inc.	$41.2M	$75,000 0.0% of portfolio	9,393	Q3 2024 New
RPRX Royalty Pharma PLC	$13.2B	$61,000 0.0% of portfolio	2,170	Q3 2024 New
CRSP Crispr Therapeutics Ag	$3.24B	$39,000 0.0% of portfolio	850	Q3 2024 New
KRYS Krystal Biotech, Inc.	$3.81B	$39,000 0.0% of portfolio	218	Q3 2024 New
ASND Ascendis Pharma A/S	$7.15B	$30,000 0.0% of portfolio	203	Q3 2024 New
SANA Sana Biotechnology, Inc.	$601M	$28,000 0.0% of portfolio	6,883	Q3 2024 New
EXEL Exelixis, Inc.	$11.7B	$18,000 0.0% of portfolio	704	Q3 2024 New
ABCL Ab Cellera Biologics Inc.	$847M	$15,000 0.0% of portfolio	5,968	Q3 2024 New
JAZZ Jazz Pharmaceuticals PLC	$7.6B	$15,000 0.0% of portfolio	139	Q3 2024 New
MRNA Moderna, Inc.	$14B	$13,000 0.0% of portfolio	199	Q3 2024 New
UTHR United Therapeutics Corp	$16.3B	$13,000 0.0% of portfolio	39	Q3 2024 New
NTLA Intellia Therapeutics, Inc.	$722M	$12,000 0.0% of portfolio	600	Q3 2024 New
GMAB Genmab A/S	$14.4B	$9,000 0.0% of portfolio	388	Q3 2024 New
INCY Incyte Corp	$16.3B	$9,000 0.0% of portfolio	146	Q3 2024 Reduced 98.83%
ADPT Adaptive Biotechnologies Corp	$973M	$7,000 0.0% of portfolio	1,450	Q3 2024 New
COGT Cogent Biosciences, Inc.	$528M	$7,000 0.0% of portfolio	730	Q3 2024 New
INSM Insmed Inc	$9.82B	$7,000 0.0% of portfolio	96	Q3 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.31B	$5,000 0.0% of portfolio	146	Q3 2024 New
CVAC Cure Vac N.V.	$769M	$4,000 0.0% of portfolio	1,682	Q3 2024 New
EXAI Exscientia PLC	$593M	$4,000 0.0% of portfolio	1,000	Q3 2024 New
STOK Stoke Therapeutics, Inc.	$369M	$4,000 0.0% of portfolio	400	Q3 2024 New
EDIT Editas Medicine, Inc.	$83.9M	$3,000 0.0% of portfolio	1,000	Q3 2024 New
HALO Halozyme Therapeutics, Inc.	$7.63B	$3,000 0.0% of portfolio	69	Q3 2024 New
IONS Ionis Pharmaceuticals Inc	$4.46B	$3,000 0.0% of portfolio	92	Q3 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$128M	$3,000 0.0% of portfolio	1,000	Q3 2024 New
ALNY Alnylam Pharmaceuticals, Inc.	$32.6B	$2,000 0.0% of portfolio	9	Q3 2024 New
GLPG Galapagos Nv	$1.56B	$2,000 0.0% of portfolio	74	Q3 2024 New
STRO Sutro Biopharma, Inc.	$105M	$2,000 0.0% of portfolio	645	Q3 2024 New
PCVX Vaxcyte, Inc.	$5.23B	$2,000 0.0% of portfolio	19	Q3 2024 New
ALEC Alector, Inc.	$141M	$1,000 0.0% of portfolio	400	Q3 2024 New
BGNE Bei Gene, Ltd.	$21.8B	$1,000 0.0% of portfolio	6	Q3 2024 New
CRNX Crinetics Pharmaceuticals, Inc.	$2.08B	$1,000 0.0% of portfolio	20	Q3 2024 New
SNDX Syndax Pharmaceuticals Inc	$740M	$1,000 0.0% of portfolio	100	Q3 2024 New
QURE Uni Qure N.V.	$657M	$1,000 0.0% of portfolio	352	Q3 2024 New
ADAP Adaptimmune Therapeutics PLC	$94.8M	$0 0.0% of portfolio	604	Q3 2024 New
BMRN Biomarin Pharmaceutical Inc	$11.6B	$0 0.0% of portfolio	2	Q3 2024 New
BNTX Bio N Tech Se	$28.5B	$0 0.0% of portfolio	7	Q3 2024 New
BPMC Blueprint Medicines Corp	$6.57B	$0 0.0% of portfolio	5	Q3 2024 New
LYRA Lyra Therapeutics, Inc.	$6.37M	$0 0.0% of portfolio	1,025	Q3 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.02B	$0 0.0% of portfolio	4	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.